Napp, A., Houbart, V., Demelenne, A., Merville, M.-P., Crommen, J., Dumoulin, M., Garraux, G., Servais, A.-C., & Fillet, M. (2018). Separation and determination of alpha-synuclein monomeric and oligomeric species using two electrophoretic approaches. Electrophoresis, 39 (23), 3022-3031. doi:10.1002/elps.201800224 Peer Reviewed verified by ORBi |
Napp, A., Houbart, V., Servais, A.-C., Merville, M.-P., Garraux, G., & Fillet, M. (19 May 2016). Analytical Challenges for the determination of alpha-synuclein and its oligomeric forms in the context of parkinson disease [Paper presentation]. Séminaire du CIRM. |
Houbart, V., COBRAIVILLE, G., Nys, G., Merville, M.-P., & Fillet, M. (2016). Impact of injection solvent composition on protein identification incolumn-switching chip-liquid chromatography/mass spectrometry. Journal of Chromatography. A, 1445, 27-35. doi:10.1016/j.chroma.2016.03.056 Peer Reviewed verified by ORBi |
Houbart, V., COBRAIVILLE, G., Servais, A.-C., Napp, A., Merville, M.-P., & Fillet, M. (2015). Hepcidin determination in dried blood by microfluidic LC-MS/MS: comparison of DBS and volumetric absorptive microsampling for matrix effect and recovery. Bioanalysis, 7 (21), 2789-99. doi:10.4155/bio.15.181 Peer Reviewed verified by ORBi |
Deroyer, C., Magne, J., Moonen, M., Le Goff, C., Dupont, L., Hulin, A., Radermecker, M., Colige, A., Cavalier, E., Kolh, P., Pierard, L., LANCELLOTTI, P., Merville, M.-P., & Fillet, M. (2015). New biomarkers for primary mitral regurgitation. Clinical Proteomics, 12, 25. doi:10.1186/s12014-015-9097-2 Peer Reviewed verified by ORBi |
De Bock, M., BEGUIN, Y., Leprince, P., WILLEMS, E., BARON, F., Deroyer, C., Seidel, L., CAVALIER, E., DE SENY, D., MALAISE, M., GOTHOT, A., MERVILLE, M.-P., & Fillet, M. (July 2014). Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers. Talanta, 125, 265-275. doi:10.1016/j.talanta.2014.03.017 Peer Reviewed verified by ORBi |
Napp, A., Garraux, G., Servais, A.-C., Merville, M.-P., & Fillet, M. (June 2014). EVALUATION OF α-SYNUCLEIN AS BIOMARKER OF PARKINSON'S DISEASE [Poster presentation]. 10th International Symposium on Drug Analysis. |
Deroyer, C., Renert, A.-F., Merville, M.-P., & Fillet, M. (2014). New role for Emerin, a key inner nuclear membrane protein, as an enhancer of the autophagosome formation in the C16-ceramide autophagy pathway. Autophagy. doi:10.4161/auto.28777 Peer Reviewed verified by ORBi |
Napp, A., Garraux, G., Servais, A.-C., Merville, M.-P., & Fillet, M. (17 October 2013). EVALUATION OF α-SYNUCLEIN AS BIOMARKER OF PARKINSON'S DISEASE [Paper presentation]. 17th Forum of Pharmaceutical Sciences, Spa, Belgium. |
De Bock, M., Fillet, M., Hannon, M., Seidel, L., Merville, M.-P., Gothot, A., Beguin, Y., & Baron, F. (2013). Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning. PLoS ONE, 8 (2), 55876. doi:10.1371/journal.pone.0055876 Peer Reviewed verified by ORBi |
Fillet, M., Deroyer, C., COBRAIVILLE, G., LE GOFF, C., Cavalier, E., Chapelle, J.-P., Marée, R., Legrand, V., Pierard, L., Kolh, P., & Merville, M.-P. (2013). Identification of protein biomarkers associated with cardiac ischemia by a proteomic approach. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 18 (7), 614-24. doi:10.3109/1354750X.2013.838306 Peer Reviewed verified by ORBi |
DEROYER, C., Renert, A.-F., Merville, M.-P., & Fillet, M. (25 May 2012). Identification of new emerin partners in ceramide signalling pathway [Paper presentation]. Belgian Society of Biochemistry and Molecular Biology: Proteomics and interactomics in signaling networks. |
Merville, M.-P., Deroyer, C., Bruyère, O., & Reginster, J.-Y. (March 2011). Strontium ranelate increases cell viability in IL-1 beta stimulated human chondrocytes [Paper presentation]. 1st IOF-ESCEO Pre-clinical Symposium (2011), European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF, Valencia, Spain. |
DE SENY, D., Sharif, M., Fillet, M., COBRAIVILLE, G., Meuwis, M.-A., Marée, R., HAUZEUR, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., Kirwan, J., Ribbens, C., & Malaise, M. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Annals of the Rheumatic Diseases, 70 (6), 1144-52. doi:10.1136/ard.2010.135541 Peer Reviewed verified by ORBi |
Merville, M.-P., Deroyer, C., Bruyère, O., & Reginster, J.-Y. (November 2010). Le ranélate de strontium augmente la viabilité de chondrocytes humains stimulés par IL-1 bêta. Revue du Rhumatisme, 77 (Suppl.3), 222. Peer Reviewed verified by ORBi |
Le Goff, C., Garweg, C., Laurent, T., Kaux, J.-F., Deroyer, C., Merville, M.-P., Melon, P., Fillet, M., Legrand, V., & Chapelle, J.-P. (July 2010). Assessment of high sensitive troponin T and I immunoassays in patients with acute chest. Clinical Chemistry, 56 (S6), 127. Peer Reviewed verified by ORBi |
Keutgens, A., Zhang-Shao, X., Shostak, K., Robert, I., Olivier, S., Vanderplasschen, A., Chapelle, J.-P., Viatour, P., Merville, M.-P., Bex, F., Gothot, A., & Chariot, A. (2010). BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1. Journal of Biological Chemistry, 285 (33), 25831–25840. doi:10.1074/jbc.M110.112128 Peer Reviewed verified by ORBi |
De Bock, M., De Seny, D., Meuwis, M.-A., Servais, A.-C., Minh, T. Q., Closset, J., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2010). Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis. Talanta, 82, 245-254. doi:10.1016/j.talanta.2010.04.029 Peer Reviewed verified by ORBi |
Robert, I., Aussems, M., Keutgens, A., Zhang-Shao, X., Hennuy, B., Viatour, P., Vanstraelen, G., Merville, M.-P., Chapelle, J.-P., de Leval, L., LAMBERT, F., Dejardin, E., Gothot, A., & Chariot, A. (02 April 2009). Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene, 28 (13), 1626-1638. doi:10.1038/onc.2009.6 Peer Reviewed verified by ORBi |
De Seny, D., Ribbens, C., Cobraiville, G., Meuwis, M.-A., Marée, R., Geurts, P., Wehenkel, L., Louis, E., Merville, M.-P., Fillet, M., & Malaise, M. (2009). Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification des protéines S100 comme protéines d'intérêt. Revue Médicale de Liège, 64 (Spec No), 29-35. Peer reviewed |
Renert, A.-F., Leprince, P., Dieu, M., Renaut, J., Raes, M., Bours, V., Chapelle, J.-P., Piette, J., Merville, M.-P., & Fillet, M. (2009). The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells. Journal of Proteome Research, 8 (10), 4810-22. doi:10.1021/pr9005316 Peer Reviewed verified by ORBi |
Quesada Calvo, F.* , Fillet, M.* , De Seny, D., Meuwis, M.-A., Marée, R., Crahay, C., Paulissen, G., Rocks, N., Guéders, M., Wehenkel, L., Merville, M.-P., Louis, R., Foidart, J.-M., Noël, A., & Cataldo, D. (2009). Biomarker discovery in asthma-related inflammation and remodeling. Proteomics, 9 (8), 2163-2170. doi:10.1002/pmic.200800643 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
De Bock, M., Merville, M.-P., Fillet, M., & Mansion, F. (Other coll.). (2009). Comparison of sample preparation for fractionation and enrichment of low molecular weight proteins [Poster presentation]. HPLC2009, Dresden, Germany. |
De Bock, M., De Seny, D., Meuwis, M.-A., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2009). Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS. Journal of Biomedicine and Biotechnology. doi:10.1155/2010/906082 Peer Reviewed verified by ORBi |
Cornez, I., Creppe, C., Gillard, M., Hennuy, B., Chapelle, J.-P., Dejardin, E., Merville, M.-P., Close, P., & Chariot, A. (June 2008). Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cells. Biochemical Pharmacology, 75, 2122-2134. doi:10.1016/j.bcp.2008.03.006 Peer Reviewed verified by ORBi |
Meuwis, M.-A.* , Fillet, M.* , Lutteri, L., Marée, R., Geurts, P., De Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L., Belaiche, J., Merville, M.-P.* , & Louis, E.*. (2008). Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clinical Biochemistry, 41 (12), 960-7. doi:10.1016/j.clinbiochem.2008.04.021 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
De Seny, D., Fillet, M., Ribbens, C., Marée, R., Meuwis, M.-A., Lutteri, L., Chapelle, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., & Malaise, M. (2008). Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clinical Chemistry, 54, 1066-1075. doi:10.1373/clinchem.2007.099549 Peer Reviewed verified by ORBi |
Meuwis, M.-A., Fillet, M., Chapelle, J.-P., Malaise, M., Louis, E., & Merville, M.-P. (2008). New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools. Expert Review of Molecular Diagnostics, 8, 327-37. doi:10.1586/14737159.8.3.327 Peer Reviewed verified by ORBi |
Lambert, C., Oury, C., Dejardin, E., Chariot, A., Piette, J., Malaise, M., Merville, M.-P., & Franchimont, N. (September 2007). Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells. Journal of Bone and Mineral Research, 22 (9), 1350-1361. doi:10.1359/jbmr.070508 Peer Reviewed verified by ORBi |
GATOT, J.-S., Gioia, R., Chau, T.-L., Warnier, M., Chapelle, J.-P., Merville, M.-P., Brown, K., Siebenlist, U., Muraille, E., Dejardin, E., Piette, J., & Chariot, A. (March 2007). Polyubiquitination of the scaffold protein tank/I-traf: implications for the TLR-mediated signalling pathways [Poster presentation]. Colloque "Chromatin Dynamics and Epigenetics" Société belge de biologie cellulaire et du développement, Liège, Belgium. |
Creppe, C., Close, P., Cornez, I., Rahmouni, S., Merville, M.-P., Chapelle, J.-P., Nusgens, C., Deroanne, C., & Chariot, A. (March 2007). A role for the transcriptional complex elongator in cell migration and spreading [Poster presentation]. Colloque "Chromatin Dynamics and Epigenetics" Société belge de biologie cellulaire et du développement, Liège, Belgium. |
Meuwis, M.-A.* , Fillet, M.* , Geurts, P., De Seny, D., Lutteri, L., Chapelle, J.-P., Bours, V., Wehenkel, L., Belaiche, J., Malaise, M., Louis, E., & Merville, M.-P. (2007). Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochemical Pharmacology, 73 (9), 1422-1433. doi:10.1016/j.bcp.2006.12.019 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Meuwis, M.-A., Louis, E., & Merville, M.-P. (2007). Contribution of proteomics to colorectal cancer diagnosis. Acta Endoscopica, 295-303. doi:10.1007/BF02961919 Peer reviewed |
Benoit, V., de Moraes, E., Dar, N. A., Taranchon, E., Bours, V., Hautefeuille, A., Taniere, P., Chariot, A., Scoazec, J. Y., Gallo, C. V. D., Merville, M.-P., & Hainaut, P. (21 September 2006). Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. Oncogene, 25 (42), 5708-5718. doi:10.1038/sj.onc.1209579 Peer Reviewed verified by ORBi |
Close, P., Hawkes, N., Cornez, I., Creppe, C., Lambert, C. A., Rogister, B., Siebenlist, U., Merville, M.-P., Slaugenhaupt, S. A., Bours, V., Svejstrup, J. Q., & Chariot, A. (May 2006). Transcription impairment and cell migration defects in elongator-depleted cells: Implication for familial dysautonomia. Molecular Cell, 22 (4), 521-531. doi:10.1016/j.molcel.2006.04.017 Peer Reviewed verified by ORBi |
Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (May 2006). Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Molecular Pharmacology, 69 (5), 1615-1623. doi:10.1124/mol.105.020479 Peer Reviewed verified by ORBi |
Relic, B., Benoit, V., Franchimont, N., Kaiser, M.-J., Hauzeur, J.-P., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2006). Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis. Journal of Biological Chemistry, 281 (32), 597-604. doi:10.1074/jbc.M512807200 Peer Reviewed verified by ORBi |
Bonif, M., Meuwis, M.-A., Close, P., Benoit, V., Heyninck, K., Chapelle, J.-P., Bours, V., Merville, M.-P., Piette, J., Beyaert, R., & Chariot, A. (2006). TNFa and IKKb-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKg and NF-kB activation. Biochemical Journal, 394, 593-603. doi:10.1042/BJ20051659 Peer Reviewed verified by ORBi |
Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (September 2005). SERMs-induced myeloma cell apoptosis: A study of NF-kappa B inhibition and gene expression signature. Journal of Bone and Mineral Research, 20 (9, Suppl. 1), 213. |
Lechanteur, C., Jacobs, N., Greimers, R., Benoit, V., Deregowski, V., Chariot, A., Merville, M.-P., & Bours, V. (03 March 2005). Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis. Oncogene, 24 (10), 1788-1793. doi:10.1038/sj.onc.1208436 Peer Reviewed verified by ORBi |
De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Fillet, M., Cren-Olive, C., Renert, A.-F., Piette, J., Vandermoere, F., Rolando, C., & Merville, M.-P. (2005). Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS. Journal of Proteome Research, 4 (3), 870-80. doi:10.1021/pr050006t Peer Reviewed verified by ORBi |
Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relic, B., Chariot, A., Bours, V., Piette, J., Merville, M.-P., & Malaise, M. (2005). Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis and Rheumatism, 52 (1), 84-93. doi:10.1002/art.20727 Peer Reviewed verified by ORBi |
Robe, P., Nguyen-Khac, M.-T., Jolois, O., Rogister, B., Merville, M.-P., & Bours, V. (2005). Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells. BMC Cancer, 5, 32. doi:10.1186/1471-2407-5-32 Peer Reviewed verified by ORBi |
Geurts, P., Fillet, M., De Seny, D., Meuwis, M.-A., Malaise, M., Merville, M.-P., & Wehenkel, L. (2005). Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics, 21 (14), 3138-45. doi:10.1093/bioinformatics/bti494 Peer Reviewed verified by ORBi |
Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (2005). Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene. Biochemical Pharmacology, 69 (6), 891-901. doi:10.1016/j.bcp.2004.11.030 Peer Reviewed verified by ORBi |
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (January 2005). Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation [letter to the editor]. Trends in Biochemical Sciences, 30 (1), 43-52. doi:10.1016/j.tibs.2004.11.009 Peer Reviewed verified by ORBi |
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (December 2004). Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity. Cell Cycle, 3 (12), 1498-1501. doi:10.4161/cc.3.12.1328 Peer Reviewed verified by ORBi |
Viatour, P., Dejardin, E., Warnier, M., Lair, F., Claudio, E., Bureau, F., Marine, J. C., Merville, M.-P., Maurer, U., Green, D., Piette, J., Siebenlist, U., Bours, V., & Chariot, A. (08 October 2004). GSK3-Mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Molecular Cell, 16 (1), 35-45. doi:10.1016/j.molcel.2004.09.004 Peer Reviewed verified by ORBi |
De Seny, D., Fillet, M., Meuwis, M.-A., Lutteri, L., Geurts, P., Wehenkel, L., Bours, V., Piette, J., Malaise, M., & Merville, M.-P. (September 2004). Discovery of new rheumatoid arthritis biomarkers using SELDI-TOF-MS ProteinChip approach. Arthritis and Rheumatism, 50 (9, Suppl. S), 124. |
Benoit, V., Relic, B., de Leval, L., Chariot, A., Merville, M.-P., & Bours, V. (February 2004). Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2. Oncogene, 23 (8), 1631-1635. doi:10.1038/sj.onc.1207295 Peer Reviewed verified by ORBi |
Robe, P., Bentires-Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., Khac, M.-T. N., Jolois, O., Erkmen, K., Merville, M.-P., Black, P. M., & Bours, V. (2004). In vitro and in vivo activity of the nuclear factor-kappa B inhibitor sulfasalazine in human glioblastomas. Clinical Cancer Research, 10 (16), 5595-603. doi:10.1158/1078-0432.CCR-03-0392 Peer Reviewed verified by ORBi |
Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M.-J., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2004). 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. Journal of Biological Chemistry, 279 (21), 399-403. doi:10.1074/jbc.M314118200 Peer Reviewed verified by ORBi |
Benoit, V., Chariot, A., Delacroix, L., Deregowski, V., Jacobs, N., Merville, M.-P., & Bours, V. (2004). Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappa B through c-FLIP-L expression. Cancer Research, 64 (8), 2684-2691. doi:10.1158/0008-5472.CAN-03-2914 Peer Reviewed verified by ORBi |
Jans, D., Martinet, W., Fillet, M., Kockx, M. M., Merville, M.-P., Bult, H., Herman, A. G., & De Meyer, G. R. Y. (2004). Effect of non-steroidal anti-inflammatory drugs on amyloid-beta formation and macrophage activation after platelet phagocytosis. Journal of Cardiovascular Pharmacology, 43 (3), 462-70. doi:10.1097/00005344-200403000-00019 Peer Reviewed verified by ORBi |
Robe, P., Jolois, O., Nguyen Khac, M.-T., Princen, Malgrange, B., Merville, M.-P., & Bours, V. (2004). Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication. International Journal of Oncology, 25 (1), 187-92. doi:10.3892/ijo.25.1.187 Peer Reviewed verified by ORBi |
De Leval, X., Dassesse, T., Benoît, V., Pirotte, B., Merville, M.-P., David, J. L., Castronovo, V., & Dogne, J. M. (December 2003). Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent [Poster presentation]. 45th ASH Annual Meeting, San Diego, United States. |
Viatour, P., Legrand-Poels, S., van Lint, C., Warnier, M., Merville, M.-P., Gielen, J.-L., Piette, J., Bours, V., & Chariot, A. (21 November 2003). Cytoplasmic I kappa B alpha increases NF-kappa B-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. Journal of Biological Chemistry, 278 (47), 46541-46548. doi:10.1074/jbc.M306381200 Peer Reviewed verified by ORBi |
de Leval, X. J., Dassesse, T., Benoit, V., Pirotte, B., Merville, M.-P., David, J.-L., Castronovo, V., & Dogné, J.-M. (16 November 2003). Pharmacological evaluation of BM-573, a dual thromboxane A(2) receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent. Blood, 102 (11, Part 2), 72. |
Lambert, C., Ribbens, C., Bours, V., Merville, M.-P., Malaise, M., & Franchimont, N. (September 2003). Identification of the signalling pathways required for interleukin-1 beta stimulation of osteoprotegerin synthesis in osteoblastic cells. Journal of Bone and Mineral Research, 18 (Suppl. 2), 142. |
Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (September 2003). Raloxifene protects Osteoblasts from apoptosis induced by sodium nitroprusside: Potential involvement of ceramide. Journal of Bone and Mineral Research, 18 (Suppl. 2), 136. |
Franchimont, N. M., Lambert, C., Ribbens, C., Huynen, P., Relic, B., Bours, V., Merville, M.-P., & Malaise, M. (September 2003). Interleukin-1beta and tumor necrosis factor-alpha enhance the shedding of Interleukin-6 receptor in osteoblastic cells: Involvement of tumor necrosis factor-alpha converting enzyme. Arthritis and Rheumatism, 48 (9, Suppl. S), 482. |
Viatour, P., Bentires-Alj, M., Chariot, A., Deregowski, V., de Leval, L., Merville, M.-P., & Bours, V. (July 2003). NF-kappa B2/p100 induces Bcl-2 expression. Leukemia, 17 (7), 1349-1356. doi:10.1038/sj.leu.2402982 Peer Reviewed verified by ORBi |
Chariot, A., Meuwis, M.-A., Bonif, M., Leonardi, A., Merville, M.-P., Gielen, J.-L., Piette, J., Siebenlist, U., & Bours, V. (April 2003). NF-kappa B activating scaffold proteins as signaling molecules and putative therapeutic targets. Current Medicinal Chemistry, 10 (7), 593-602. doi:10.2174/0929867033457926 Peer Reviewed verified by ORBi |
Frederich, M., Bentires-Alj, M., Tits, M., Angenot, L., Greimers, R., Gielen, J., Bours, V., & Merville, M.-P. (March 2003). Isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis, induces cell cycle arrest and apoptosis in human colon cancer cells. Journal of Pharmacology and Experimental Therapeutics, 304 (3), 1103-1110. doi:10.1124/jpet.102.044867 Peer Reviewed verified by ORBi |
Fillet, M., Bentires-Alj, M., Deregowski, V., Greimers, R., Gielen, J.-L., Piette, J., Bours, V., & Merville, M.-P. (2003). Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity. Biochemical Pharmacology, 65 (10), 1633-42. doi:10.1016/S0006-2952(03)00125-4 Peer Reviewed verified by ORBi |
De Leval, X., Dassesse, T., Benoit, V., Pirotte, B., David, J.-L., Merville, M.-P., Castronovo, V., & Dogné, J.-M. (2003). Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent. Blood, 72. Peer Reviewed verified by ORBi |
Viatour, P., Legrand-Poels, S., Van Lint, C., Warnier, M., Merville, M.-P., Gielen, J., Piette, J., BOURS, V., & Chariot, A. (2003). Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histones deacetylases (HDAC1 and HDAC3). Journal of Biological Chemistry. Peer Reviewed verified by ORBi |
De Leval, X., Benoit, V., Delarge, J., Julémont, F., Masereel, B., Pirotte, B., Merville, M.-P., David, J. L., & Dogné, J.-M. (2003). Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 55-59. doi:10.1016/S0952-3278(02)00235-1 Peer Reviewed verified by ORBi |
Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V. (2003). NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 22, 90-97. doi:10.1038/sj.onc.1206056 Peer Reviewed verified by ORBi |
Delhalle, S., Deregowski, V., Benoit, V., Merville, M.-P., & Bours, V. (2002). NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene, 21 (24), 3917-24. doi:10.1038/sj.onc.1205489 Peer Reviewed verified by ORBi |
Deregowski, V., Delhalle, S., Benoit, V., Bours, V., & Merville, M.-P. (2002). Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells. Biochemical Pharmacology, 64 (5-6), 873-81. doi:10.1016/S0006-2952(02)01151-6 Peer Reviewed verified by ORBi |
Relic, B., Bentires-Alj, M., Ribbens, C., Franchimont, N., Guerne, P.-A., Benoit, V., Merville, M.-P., Bours, V., & Malaise, M. (2002). TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB. Laboratory Investigation, 82 (12), 1661-1672. doi:10.1097/01.LAB.0000041714.05322.C0 Peer Reviewed verified by ORBi |
De Leval, X., David, J. L., Neven, P., Benoit, V., Pirotte, B., Merville, M.-P., Bours, V., & Dogne, J. M. (December 2001). Effects of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, on osteogenic sarcoma cell-induced platelet aggregation [Poster presentation]. The 43rd ASH Annual Meeting, Orlando, United States. |
de Leval, X., David, J.-L., Neven, P., Benoit, V., Pirotte, B., Merville, M.-P., Bours, V., & Dogné, J.-M. (16 November 2001). Effects of BM-573, a dual thromboxane A(2) receptor antagonist and thromboxane synthase inhibitor, on osteogenic sarcoma cell-induced platelet aggregation. Blood, 98 (11, Part 2), 43. Peer Reviewed verified by ORBi |
Fievez, L., Kirschvink, N., Dogne, S., Jaspar, F., Merville, M.-P., Bours, V., Lekeux, P., & Bureau, F. (01 September 2001). Impaired Accumulation of Granulocytes in the Lung During Ozone Adaptation. Free Radical Biology and Medicine, 31 (5), 633-641. doi:10.1016/S0891-5849(01)00621-9 Peer Reviewed verified by ORBi |
Bentires-Alj, M., Dejardin, E., Viatour, P., Van Lint, C., Froesch, B., Reed, J. C., Merville, M.-P., & Bours, V. (11 May 2001). Inhibition of the Nf-Kappa B Transcription Factor Increases Bax Expression in Cancer Cell Lines. Oncogene, 20 (22), 2805-13. doi:10.1038/sj.onc.1204343 Peer Reviewed verified by ORBi |
Princen, F., Robe, P., Gros, D., Jarry-Guichard, T., Gielen, J., Merville, M.-P., & Bours, V. (March 2001). Rat Gap Junction Connexin-30 Inhibits Proliferation of Glioma Cell Lines. Carcinogenesis, 22 (3), 507-13. doi:10.1093/carcin/22.3.507 Peer Reviewed verified by ORBi |
Hellin, A.-C., Bentires-Alj, M., Verlaet, M., Benoit, V., Bours, V., & Merville, M.-P. (December 2000). Roles of Nuclear Factor-Kappab, P53, and P21/Waf1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis. Journal of Pharmacology and Experimental Therapeutics, 295 (3), 870-8. Peer Reviewed verified by ORBi |
Bours, V., Bonizzi, G., Bentires-Alj, M., Bureau, F., Piette, J., Lekeux, P., & Merville, M.-P. (16 November 2000). Nf-Kappab Activation in Response to Toxical and Therapeutical Agents: Role in Inflammation and Cancer Treatment. Toxicology, 153 (1-3), 27-38. doi:10.1016/S0300-483X(00)00302-4 Peer Reviewed verified by ORBi |
Bureau, F., Delhalle, S., Bonizzi, G., Fievez, L., Dogne, S., Kirschvink, N., Vanderplasschen, A., Merville, M.-P., Bours, V., & Lekeux, P. (15 November 2000). Mechanisms of Persistent Nf-Kappa B Activity in the Bronchi of an Animal Model of Asthma. Journal of Immunology, 165 (10), 5822-5830. doi:10.4049/jimmunol.165.10.5822 Peer Reviewed verified by ORBi |
Bours, V., Bentires-Alj, M., Hellin, A.-C., Viatour, P., Robe, P., Delhalle, S., Benoit, V., & Merville, M.-P. (15 October 2000). Nuclear Factor-Kappa B, Cancer, and Apoptosis. Biochemical Pharmacology, 60 (8), 1085-9. doi:10.1016/S0006-2952(00)00391-9 Peer Reviewed verified by ORBi |
Benoit, V., Hellin, A.-C., Huygen, S., Gielen, J., Bours, V., & Merville, M.-P. (28 September 2000). Additive Effect between Nf-Kappab Subunits and P53 Protein for Transcriptional Activation of Human P53 Promoter. Oncogene, 19 (41), 4787-94. doi:10.1038/sj.onc.1203831 Peer Reviewed verified by ORBi |
Robe, P., Rogister, B., Merville, M.-P., & Bours, V. (11 September 2000). Growth Regulation of Astrocytes and C6 Cells by Tgfbeta1: Correlation with Gap Junctions. Neuroreport, 11 (13), 2837-41. doi:10.1097/00001756-200009110-00003 Peer Reviewed verified by ORBi |
Lechanteur, C., Delvenne, P., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J., Merville, M.-P., & Bours, V. (September 2000). Combined Suicide and Cytokine Gene Therapy for Peritoneal Carcinomatosis. Gut, 47 (3), 343-8. doi:10.1136/gut.47.3.343 Peer Reviewed verified by ORBi |
Robe, P., Princen, F., Martin, D., Malgrange, B., Stevenaert, A., Moonen, G., Gielen, J.-L., Merville, M.-P., & Bours, V. (15 July 2000). Pharmacological Modulation of the Bystander Effect in the Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy System: Effects of Dibutyryl Adenosine 3',5'-Cyclic Monophosphate, Alpha-Glycyrrhetinic Acid, and Cytosine Arabinoside. Biochemical Pharmacology, 60 (2), 241-9. doi:10.1016/S0006-2952(00)00315-4 Peer Reviewed verified by ORBi |
Lechanteur, C., Moutschen, M., Princen, F., Lopez, M.-J., Franzen, E., Gielen, J., Bours, V., & Merville, M.-P. (May 2000). Antitumoral Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-12-Expressing Dhd/K12 Colon Adenocarcinoma Cells. Cancer Gene Therapy, 7 (5), 676-82. doi:10.1038/sj.cgt.7700152 Peer Reviewed verified by ORBi |
Bonizzi, G., Piette, J., Merville, M.-P., & Bours, V. (01 January 2000). Cell Type-Specific Role for Reactive Oxygen Species in Nuclear Factor-Kappab Activation by Interleukin-1. Biochemical Pharmacology, 59 (1), 7-11. doi:10.1016/S0006-2952(99)00290-7 Peer Reviewed verified by ORBi |
Princen, F., Lechanteur, C., Lopez, M.-J., Gielen, J., Bours, V., & Merville, M.-P. (2000). Similar Efficiency of DNA-Liposome Complexes and Retrovirus-Producing Cells for Hsv-Tk Suicide Gene Therapy of Peritoneal Carcinomatosis. Journal of Drug Targeting, 8 (2), 79-89. doi:10.3109/10611860008996854 Peer Reviewed verified by ORBi |
Bentires-Alj, M., Hellin, A.-C., Lechanteur, C., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J.-L., Merville, M.-P., & Bours, V. (January 2000). Cytosine Deaminase Suicide Gene Therapy for Peritoneal Carcinomatosis. Cancer Gene Therapy, 7 (1), 20-6. doi:10.1038/sj.cgt.7700093 Peer Reviewed verified by ORBi |
Chariot, A., Gielen, J., Merville, M.-P., & Bours, V. (December 1999). The homeodomain-containing proteins: an update on their interacting partners. Biochemical Pharmacology, 58, 1851-1857. doi:10.1016/S0006-2952(99)00234-8 Peer Reviewed verified by ORBi |
Princen, F., Robe, P., Lechanteur, C., Mesnil, M., Rigo, J.-M., Gielen, J., Merville, M.-P., & Bours, V. (November 1999). A Cell Type-Specific and Gap Junction-Independent Mechanism for the Herpes Simplex Virus-1 Thymidine Kinase Gene/Ganciclovir-Mediated Bystander Effect. Clinical Cancer Research, 5 (11), 3639-44. Peer Reviewed verified by ORBi |
Matroule, J. Y., Hellin, A.-C., Morliere, P., Fabiano, A. S., Santus, R., Merville, M.-P., & Piette, J. (October 1999). Role of Nuclear Factor-Kappa B in Colon Cancer Cell Apoptosis Mediated by Aminopyropheophorbide Photosensitization. Photochemistry and Photobiology, 70 (4), 540-8. doi:10.1111/j.1751-1097.1999.tb08249.x Peer Reviewed verified by ORBi |
Bentires-Alj, M., Merville, M.-P., & Bours, V. (August 1999). Nf- Kappa B and Chemoresistance: Could Nf- Kappa B Be an Antitumor Target? Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 2 (4), 274-276. doi:10.1054/drup.1999.0093 Peer Reviewed verified by ORBi |
Dejardin, E., Deregowski, V., Chapelier, M., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V. (22 April 1999). Regulation of Nf-Kappab Activity by I Kappab-Related Proteins in Adenocarcinoma Cells. Oncogene, 18 (16), 2567-77. doi:10.1038/sj.onc.1202599 Peer Reviewed verified by ORBi |
Bonizzi, G., Piette, J., Haterte, S., Merville, M.-P., & Bours, V. (15 March 1999). Role of the Protein Kinase C Lambda/Iota Isoform in Nuclear Factor-Kappab Activation by Interleukin-1beta or Tumor Necrosis Factor-Alpha: Cell Type Specificities. Biochemical Pharmacology, 57 (6), 713-20. doi:10.1016/S0006-2952(98)00353-0 Peer Reviewed verified by ORBi |
Bonizzi, G., Piette, J., Haterte, S., Greimers, R., Havard, L., Merville, M.-P., & Bours, V. (March 1999). Reactive Oxygen Intermediate-Dependent Nf-Kappab Activation by Interleukin-1beta Requires 5-Lipoxygenase or Nadph Oxidase Activity. Molecular and Cellular Biology, 19 (3), 1950-60. doi:10.1128/mcb.19.3.1950 Peer Reviewed verified by ORBi |
Chariot, A., Princen, F., Gielen, J., Merville, M.-P., Franzoso, G., Brown, K., Siebenlist, U., & Bours, V. (10 February 1999). Ikappab-Alpha Enhances Transactivation by the Hoxb7 Homeodomain-Containing Protein. Journal of Biological Chemistry, 274 (9), 5318-25. doi:10.1074/jbc.274.9.5318 Peer Reviewed verified by ORBi |
Bentires-Alj, M., Hellin, A.-C., Ameyar, M., Chouaib, S., Merville, M.-P., & Bours, V. (10 February 1999). Stable Inhibition of Nuclear Factor Kappab in Cancer Cells Does Not Increase Sensitivity to Cytotoxic Drugs. Cancer Research, 59 (4), 811-5. Peer Reviewed verified by ORBi |
Chariot, A., Van Lint, C., Chapelier, M., Gielen, J., Merville, M.-P., & Bours, V. (1999). CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene, 18, 4007-4012. doi:10.1038/sj.onc.1202776 Peer Reviewed verified by ORBi |
Princen, F., Lechanteur, C., Lopez Y Cadenas, M., Rocoux, G., Detroz, B., Gielen, J.-L., Fillet, G., Merville, M.-P., & Bours, V. (August 1998). Repeated Cycles of Retrovirus-Mediated Hsvtk Gene Transfer Plus Ganciclovir Increase Survival of Rats with Peritoneal Carcinomatosis. Gene Therapy, 5 (8), 1054-60. doi:10.1038/sj.gt.3300710 Peer Reviewed verified by ORBi |
Defechereux-Thibaut de Maisières, P., Baudoux-Tebache, L., Merville, M.-P., Rentier, B., Bours, V., & Piette, J. (May 1998). Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich region. Journal of Biological Chemistry, 273 (22), 13636-13644. Peer Reviewed verified by ORBi |
Hellin, A.-C., Calmant, P., Bours, V., Merville, M.-P., & Gielen, J. (05 March 1998). Nuclear Factor - Kappab-Dependent Regulation of P53 Gene Expression Induced by Daunomycin Genotoxic Drug. Oncogene, 16 (9), 1187-95. doi:10.1038/sj.onc.1201638 Peer Reviewed verified by ORBi |
Lechanteur, C., Princen, F., Lo Bue, S., Detroz, B., Fillet, G., Gielen, J., Bours, V., & Merville, M.-P. (1998). Hsv-1 Thymidine Kinase Gene Therapy for Peritoneal Carcinomatosis. Advances in Experimental Medicine and Biology, 451, 115-9. doi:10.1007/978-1-4615-5357-1_18 Peer Reviewed verified by ORBi |
Dejardin, E., Deregowski, V., GREIMERS, R., Cai, Z., Chouaib, S., Merville, M.-P., & BOURS, V. (1998). Regulation of major histocompatibility complex class I expression by NF-kB-related proteins in breast cancer cells. Oncogene. doi:10.1038/sj.onc.1201879 Peer Reviewed verified by ORBi |
Bonizzi, G., Piette, J., Merville, M.-P., & Bours, V. (01 December 1997). Distinct Signal Transduction Pathways Mediate Nuclear Factor-Kappab Induction by Il-1beta in Epithelial and Lymphoid Cells. Journal of Immunology, 159 (11), 5264-72. Peer Reviewed verified by ORBi |
Piette, J., Piret, B., Bonizzi, G., Schoonbroodt, S., Merville, M.-P., Legrand-Poels, S., & Bours, V. (November 1997). Multiple Redox Regulation in Nf-Kappab Transcription Factor Activation. Biological Chemistry, 378 (11), 1237-45. Peer Reviewed verified by ORBi |
Lechanteur, C., Princen, F., Lo Bue, S., Detroz, B., Fillet, G., Gielen, J.-L., Bours, V., & Merville, M.-P. (November 1997). Hsv-1 Thymidine Kinase Gene Therapy for Colorectal Adenocarcinoma-Derived Peritoneal Carcinomatosis. Gene Therapy, 4 (11), 1189-94. doi:10.1038/sj.gt.3300520 Peer Reviewed verified by ORBi |
Bonizzi, G., Dejardin, E., Piret, B., Piette, J., Merville, M.-P., & Bours, V. (15 December 1996). Interleukin-1 Beta Induces Nuclear Factor Kappa B in Epithelial Cells Independently of the Production of Reactive Oxygen Intermediates. European Journal of Biochemistry, 242 (3), 544-9. doi:10.1111/j.1432-1033.1996.0544r.x Peer Reviewed verified by ORBi |
Rentier, B., Piette, J., Baudoux, L., Debrus, S., Defechereux, P., Merville, M.-P., Sadzot-Delvaux, C., & Schoonbroodt, S. (November 1996). Lessons to be learned from varicella-zoster virus. Veterinary Microbiology, 53 (1-2), 55-66. doi:10.1016/S0378-1135(96)01234-5 Peer Reviewed verified by ORBi |
Schoonbroodt, S., Piette, J., Baudoux, L., Defechereux, P., Rentier, B., & Merville, M.-P. (August 1996). Enhancement of Varicella-Zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins. Journal of Medical Virology, 49 (4), 264-273. doi:10.1002/(SICI)1096-9071(199608)49:4<264::AID-JMV2>3.0.CO;2-1 Peer Reviewed verified by ORBi |
Defechereux, P., Debrus, S., Baudoux, L., Schoonbroodt, S., Merville, M.-P., Rentier, B., & Piette, J. (July 1996). Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein. Journal of General Virology, 77 (Part 7), 1505-1513. doi:10.1099/0022-1317-77-7-1505 Peer Reviewed verified by ORBi |
Defechereux, P., Baudoux, L., Merville, M.-P., Bours, V., Rentier, B., & Piette, J. (1996). Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus ORF4 encoded protein involves binding sites for nuclear factor kappa B [Paper presentation]. 21st International Herpesvirus Workshop, De Kalb, Illinois, United States. |
Dejardin, E., Bonizzi, G., Bellahcene, A., Castronovo, V., Merville, M.-P., & Bours, V. (02 November 1995). Highly-Expressed P100/P52 (Nfkb2) Sequesters Other Nf-Kappa B-Related Proteins in the Cytoplasm of Human Breast Cancer Cells. Oncogene, 11 (9), 1835-41. Peer Reviewed verified by ORBi |
Baudoux, L., Defechereux, P., Schoonbroodt, S., Merville, M.-P., Rentier, B., & Piette, J. (25 April 1995). Mutational analysis of varicella-zoster virus major immediate-early protein IE62. Nucleic Acids Research, 23 (8), 1341-1349. doi:10.1093/nar/23.8.1341 Peer Reviewed verified by ORBi |
Charlier, C., Chariot, A., Antoine, N., Merville, M.-P., Gielen, J., & Castronovo, V. (January 1995). Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochemical Pharmacology, 49, 351-358. doi:10.1016/0006-2952(94)00492-5 Peer Reviewed verified by ORBi |
Piette, J., Defechereux, P., Baudoux, L., Debrus, S., Merville, M.-P., & Rentier, B. (1995). Varicella-zoster virus gene regulation. Neurology, 45 (12, suppl. 8), 23-S27. doi:10.1212/wnl.45.12_suppl_8.s23 Peer Reviewed verified by ORBi |
Schoonbroodt, S., Piette, J., Baudoux, L., Defechereux, P., Rentier, B., & Merville, M.-P. (1995). Enhancement of Varicella-Zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins [Paper presentation]. 20th International Herpesvirus Workshop, Groningen, Netherlands. |
Bellahcene, A., Merville, M.-P., & Castronovo, V. (01 June 1994). Expression of Bone Sialoprotein, a Bone Matrix Protein, in Human Breast Cancer. Cancer Research, 54 (11), 2823-6. Peer Reviewed verified by ORBi |
Bellahcene, A., Merville, M.-P., Gielen Jacques, Lambotte, R., Simar, L., & Castronovo, V. (01 May 1994). La protéine P53, protectrice de l'intégrité du génome: rôle dans la genèse des cancers. Revue Médicale de Liège, 49 (5), 274-84. Peer reviewed |
Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M.-P., & Castronovo, V. (13 January 1994). The Nf-Kappa B Transcription Factor and Cancer: High Expression of Nf-Kappa B- and I Kappa B-Related Proteins in Tumor Cell Lines. Biochemical Pharmacology, 47 (1), 145-9. doi:10.1016/0006-2952(94)90448-0 Peer Reviewed verified by ORBi |
Defechereux, P., Baudoux, L., Lambert, C., Merville, M.-P., Rentier, B., & Piette, J. (1994). VZV ORF 4 encoded protein is an effective transactivor of gene expression and possesses distinct regulatory properties [Paper presentation]. 2nd International Conference on the Varicella-Zoster Virus, Paris, France. |
Charlier, C., Colin, C., Merville, M.-P., Lambotte, R., Plomteux, G., Castronovo, V., & Gielen, J. (1994). Le tamoxifene dans le traitement du cancer du sein. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction, 23 (7), 751-6. Peer Reviewed verified by ORBi |
Defechereux, P., Melen-Lamalle, L., Baudoux, L., Merville, M.-P., Rentier, B., & Piette, J. (July 1993). Characterization of the regulatory functions of varicella-zoster virus open reading frame-4 gene-product. Journal of Virology, 67 (7), 4379-4385. doi:10.1128/jvi.67.7.4379-4385.1993 Peer Reviewed verified by ORBi |
Lauricella-Lefebvre, M. A., Castronovo, V., Sato, H., Seiki, M., French, D. L., & Merville, M.-P. (1993). Stimulation of the 92-Kd Type Iv Collagenase Promoter and Enzyme Expression in Human Melanoma Cells. Invasion and Metastasis, 13 (6), 289-300. Peer Reviewed verified by ORBi |
Jackers, P., Defechereux, P., Baudoux, L., Merville, M.-P., Rentier, B., & Piette, J. (22 February 1992). Varicella-zoster gene 63 encoded protein is an important regulatory factor. Archives Internationales de Physiologie, de Biochimie et de Biophysique, 100, 52. Peer Reviewed verified by ORBi |
Defechereux, P., Baudoux, L., Jackers, P., Merville, M.-P., Rentier, B., & Piette, J. (22 February 1992). Molecular characterization of varicella-zoster virus gene expression. Archives Internationales de Physiologie, de Biochimie et de Biophysique, 100, 40. Peer Reviewed verified by ORBi |
Piette, J., Defechereux, P., Baudoux, L., Melen-Lamalle, L., Debrus, S., Sadzot-Delvaux, C., Merville, M.-P., & Rentier, B. (1992). La régulation de l'expression des gènes du virus de la varicelle et du zona. Annales de Médecine Vétérinaire, 136 (8), 627-635. Peer Reviewed verified by ORBi |
Sadzot-Delvaux, C., Marc, P., Lebon, L., Merville, M.-P., Piette, J., & Rentier, B. (1992). Antibodies to varicella-zoster virus modulate antigen distribution but fail to induce viral persistence in vitro. Journal of Virology, 66 (12), 7499-504. doi:10.1128/jvi.66.12.7499-7504.1992 Peer Reviewed verified by ORBi |
Jackers, P., Defechereux, P., Baudoux, L., Lambert, C., Massaer, M., Merville, M.-P., Rentier, B., & Piette, J. (1992). Characterization of regulatory functions of the varicella-zoster virus gene-63-encoded protein. Journal of Virology, 66 (6), 3899-3903. doi:10.1128/jvi.66.6.3899-3903.1992 Peer Reviewed verified by ORBi |
Sadzot-Delvaux, C., Merville, M.-P., Delrée, P., Marc, P., Piette, J., Moonen, G., & Rentier, B. (May 1990). An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. Journal of Neuroscience Research, 26 (1), 83-89. doi:10.1002/jnr.490260110 Peer Reviewed verified by ORBi |
Bourdon-Wouters, C., Merville, M.-P., Sadzot-Delvaux, C., Marc, P., Piette, J., Delrée, P., Moonen, G., & Rentier, B. (May 1990). Acute and persistent varicella-zoster virus infection of human and murine neuroblastoma cell lines. Journal of Neuroscience Research, 26 (1), 90-97. doi:10.1002/jnr.490260111 Peer Reviewed verified by ORBi |
Sadzot-Delvaux, C., Merville, M.-P., Delrée, P., Marc, P., Piette, J., Moonen, G., & Rentier, B. (1989). Latent infection in vivo by the varicella-zoster virus (VZV) in the rat nervous system. Archives Internationales de Physiologie et de Biochimie, 97, 180. Peer Reviewed verified by ORBi |
Marc, P., Sadzot-Delvaux, C., Merville, M.-P., Piette, J., & Rentier, B. (1989). Antibodies to varicella-zoster virus modulate antigen distribution in cultured infected cells. Archives Internationales de Physiologie et de Biochimie, 97, 165. |
Sadzot-Delvaux, C., Merville, M.-P., Bourdon-Wouters, C., Delrée, P., Marc, P., Piette, J., Moonen, G., & Rentier, B. (1988). Persistent varicella-zoster virus infection in the nervous system: in vitro and in vivo models. Acta Neurologica Belgica, 88, 312. |
Sadzot-Delvaux, C., Merville, M.-P., Bourdon-Wouters, C., Delrée, P., Piette, J., Moonen, G., & Rentier, B. (1988). In vitro and in vivo models of varicella-zoster virus persistence in the nervous system. Journal of Cellular Biochemistry, 12C, 30. Peer Reviewed verified by ORBi |
Sadzot-Delvaux, C., Merville, M.-P., Bourdon-Wouters, C., Delrée, P., Marc, P., Piette, J., Moonen, G., & Rentier, B. (1988). Modèles expérimentaux in vitro et in vivo de la persistance du virus de la varicelle et du zona dans le système nerveux [Paper presentation]. Réunion de la Société Belge de Neurologie, Liège, Belgium. |
Bourdon-Wouters, C., Merville, M.-P., Piette, J., Sadzot-Delvaux, C., & Rentier, B. (1988). In vitro neuroblastoma cell infection by varicella-zoster virus [Poster presentation]. 13th International Herpesvirus Workshop, Irvine, United States - California. |
Sadzot-Delvaux, C., Merville, M.-P., Bourdon-Wouters, C., Delrée, P., Piette, J., Moonen, G., & Rentier, B. (1988). In vitro and in vivo models of varicella-zoster virus persistence in the nervous system [Poster presentation]. U.C.L.A. Symposium on Molecular and Cellular Biology, Taos, United States. |
Bourdon-Wouters, C., Sadzot-Delvaux, C., Merville, M.-P., Piette, J., & Rentier, B. (1987). Detection of cytomegalovirus with labeled DNA probes [Poster presentation]. 7ème Congrès International de Virologie, Edmonton, Canada. |
Merville, M.-P., Sadzot-Delvaux, C., Delrée, P., Moonen, G., Piette, J., & Rentier, B. (1987). Varicella-zoster virus infection of nerve cells : in situ detection by genomic probes [Poster presentation]. 7ème Congrès International de Virologie, Edmonton, Canada. |
Merville, M.-P., Sadzot-Delvaux, C., Delrée, P., Piette, J., Rentier, B., & Moonen, G. (1987). Molecular cloning of varicella-zoster virus DNA and its detection in situ in infected nerve cells. Archives Internationales de Physiologie et de Biochimie, 95 (2), 31. Peer Reviewed verified by ORBi |
Bourdon-Wouters, C., Merville, M.-P., Sadzot-Delvaux, C., Piette, J., & Rentier, B. (1987). Detection and identification of the cytomegalovirus genome in infected cells with labeled DNA probes. Archives Internationales de Physiologie et de Biochimie. Peer Reviewed verified by ORBi |
Merville, M.-P., Sadzot-Delvaux, C., Piette, J., Delrée, P., Rentier, B., & Moonen, G. (1987). Detection of varicella-zoster virus (VZV) genome in infected cells using cloned DNA probes. Acta Neurologica Belgica, 87, 43-44. |
Merville, M.-P., Sadzot-Delvaux, C., Piette, J., & Rentier, B. (1986). Detection of varicella-zoster virus (VZV) genome in infected cells using cloned DNA probes [Paper presentation]. N.A.T.O. Summer School, Maratea, Italy. |
Decuyper, J., Piette, J., Rentier, B., Merville, M.-P., & Van de Vorst, A. (1984). Effect of DNA photosensitization mediated by promazine derivatives on transcription in vitro. Archives Internationales de Physiologie et de Biochimie, 92 (2), 18. |